A man with multiple sclerosis (MS) is about to undertake a feat of physical and mental endurance. Dominic Shadbolt, 53, from ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

Scientists at the University of Edinburgh are using the small minnow fish to study how MS damages the protective coating ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Tolebrutinib, a brain-penetrant BTK inhibitor, may fill a significant unmet need by delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis.

Dr. Stephen Hauser, a Ross resident who is a neurology professor at UCSF, “overturned the scientific consensus” about the ...

We are asking for the opportunity to live safely, close to those who support us so that Gary can live with dignity and more readily engage in family life and as a father' ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

Multiple sclerosis is an autoimmune condition that affects your central nervous system. The condition causes your immune system to attack the myelin cells, the protective sheaths surrounding your ...